Douglas Laboratories® Introduces Ultra HNS, a New Cynatine®-Based Product

Share Article

A Beauty-From-Within Exclusive Distribution

Douglas Laboratories®, the trusted choice of thousands of healthcare professionals for superior quality, science-based nutritional supplements for over 50 years, introduces Ultra HNS (Hair, Nails Skin Formula), based on the clinically-studied ingredient Cynatine®HNS.

Douglas Laboratories in collaboration with Atrium Innovations has obtained exclusive rights for two years to Cynatine®HNS from Roxlor, LLC, for North American healthcare professionals. Cynatine® is a solubilized sheep’s wool keratin that promotes the health of hair, nails and skin – bringing out beauty from within. Ultra HNS combines Cynatine® with biotin, folate, zinc, PABA and lemon bioflavonoids, helping to create a healthy, natural look from head to toe.

Roxlor recently conducted a new human clinical trial examining the benefits of Cynatine® on hair, nails and skin over a 30 to 90 day period. In their results publicized today, Cynatine® was reported to reduce everyday hair loss by up to 46 percent, while promoting hair growth, strength and shine. Cynatine also enforced the strength and appearance of healthy nails. Taken orally, Cynatine reduces the overall appearance and depth of wrinkles and promotes skin integrity and elasticity, while at the same time improving skin moisture by up to 30 percent, when compared with placebo.

“The combination of solubilized keratin and high dose biotin in Ultra HNS is a unique formula with positive clinical results that will benefit my patients tremendously,” says Dr. Shelena Lalji of Dr. Shel Wellness and Medical Spa in Sugarland, TX. “With the latest Cynatine® results, patients can take comfort in the quality and effectiveness of Cynatine® as the active ingredient in Ultra HNS.”

“The launch of Ultra HNS underscores the leadership of Douglas Laboratories and the value of Atrium’s Innovation Committee, which is our collaborative product development think tank,” says Dr. Barry Ritz, Vice-President, Scientific and Regulatory Affairs for Atrium Innovations. “Roxlor has been an ideal partner in our quest to bring this clinically-studied ingredient to health care professionals and take beauty from within to the next level.”

ABOUT DOUGLAS LABORATORIES®
A subsidiary of Atrium Innovations Inc. [TSX: ATB], Douglas Laboratories®, the trusted choice of thousands of healthcare professionals for over 50 years, is at the forefront of the nutritional health industry, proudly researching, developing and manufacturing superior quality, science-based supplements that help people improve their health. Douglas Laboratories provides added insurance of multiple domestic and international GMP certifications, including ISO-9001 Certification and ISO-17025 Accreditation for in-house laboratories, as well as NSF International Registration. Douglas Laboratories currently offers over 600 branded products. Douglas Laboratories distributes worldwide, with its headquarters located in Pittsburgh, Pennsylvania, USA. For additional information, please visit http://www.douglaslabs.com.

ABOUT ATRIUM INNOVATIONS
Atrium Innovations Inc. is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based dietary supplements available mainly through healthcare practitioners and health food and specialized stores. Atrium has over 1,100 employees and operates eight manufacturing facilities. Additional information is available at http://www.atrium-innovations.com

ABOUT THE ROXLOR GROUP
The Roxlor Group headquartered in Wilmington, Delaware with operations in the United States, Europe and Asia, manufactures high quality two-piece hard gelatin capsules for the pharmaceutical and dietary supplement markets AND manufacturers and markets innovative nutraceutical and cosmeceutical ingredients for the North American, European and Asian dietary supplement and food markets. Roxlor’s branded ingredients are sustainable and backed by sound scientific evidence. Please visit http://www.Roxlor.com for more information.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Meredith Blake Matthews
Follow us on
Visit website